ATC code L01
Abemaciclib
Acalabrutinib
Acute lymphoblastic leukemia
Adagrasib
Adenosine triphosphate
Afatinib
Aflibercept
Alectinib
Alemtuzumab
Alpelisib
Alzheimer's disease
American Society of Health-System Pharmacists
Amivantamab
Anaplastic lymphoma kinase
Anatomical Therapeutic Chemical Classification System
Anemia
Antineoplastic
Apoptosis
Asciminib
Atezolizumab
Aumolertinib
Avapritinib
Avelumab
Axatilimab
Axitinib
BRAF (gene)
Baricitinib
Belantamab mafodotin
Bermekimab
Bevacizumab
Bibcode (identifier)
Binimetinib
Bioavailability
Blinatumomab
Bloodâ€“brain barrier
Bosutinib
Brentuximab vedotin
Brigatinib
Bruton's tyrosine kinase
CAS Registry Number
CD135
CD20
CD30
CD33
CD3 (immunology)
CD52
CDK inhibitor
Cabozantinib
Cancer
Cancer cell
Cancer immunotherapy
Capmatinib
Cardiotoxicity
Catumaxomab
Cediranib
Cemiplimab
Ceritinib
Cetuximab
ChemSpider
Chemical formula
Chemotherapy
Chronic myelogenous leukemia
Cobimetinib
CompTox Chemicals Dashboard
Copanlisib
Cosibelimab
Crizotinib
Dabrafenib
Dacomitinib
DailyMed
Dalpiciclib
Daratumumab
Dasatinib
Denileukin diftitox
Dexamethasone
Doi (identifier)
Dostarlimab
Durvalumab
Duvelisib
EML4
Edrecolomab
Elotuzumab
Elranatamab
Encorafenib
Enfortumab vedotin
Entrectinib
Epcoritamab
Epidermal growth factor receptor
ErbB
Erdafitinib
Erlotinib
Erythropoietin
Everolimus
Exotoxin
Fedratinib
Fibroblast growth factor receptor
Filgotinib
Food and Drug Administration
Fruquintinib
Fusion protein
Futibatinib
Gefitinib
Gemtuzumab ozogamicin
Gilteritinib
Glasdegib
Glofitamab
Half-life
Hdl (identifier)
Hedgehog signaling pathway
ISBN (identifier)
Ibritumomab tiuxetan
Ibrutinib
Icotinib
Idelalisib
Inavolisib
Infigratinib
Inotuzumab ozogamicin
Interleukin 2
Ipilimumab
Isatuximab
Janus kinase
KRAS
Lapatinib
Liver